Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1 Interventional

Nutrition, Neuromuscular Electrical Stimulation (NMES) and Secondary Progressive Multiple Sclerosis (SPMS)

ClinicalTrials.gov ID: NCT01381354

Public ClinicalTrials.gov record NCT01381354. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 10:18 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT01381354
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
University of Iowa
Other
Enrollment
38 participants

Conditions and interventions

Interventions

  • Progressive exercise Other
  • Neuromuscular electrical stimulation delivered using the electrical therapy device EMPI 300 PV Device
  • Modified paleolithic diet Other
  • Omega 3 fatty acids Dietary Supplement
  • Full Spectrum vitamin Dietary Supplement
  • Essential - hydroxytyrosol Dietary Supplement
  • Maltodextrin fiber supplement Dietary Supplement
  • Mineral boost (magnesium) Dietary Supplement
  • Niacinamide Dietary Supplement
  • Methyl B12 Dietary Supplement
  • Taurine Dietary Supplement
  • creatine Dietary Supplement
  • thiamine Dietary Supplement
  • riboflavin Dietary Supplement
  • N acetylcysteine Dietary Supplement
  • alpha lipoic acid Dietary Supplement
  • L acetyl carnitine Dietary Supplement
  • methyl folate Dietary Supplement
  • coenzyme Q Dietary Supplement
  • meditation Behavioral
  • self massage Behavioral
  • learning Behavioral
  • Coconut oil Dietary Supplement

Other · Device · Dietary Supplement + 1 more

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2010
Primary completion
Jan 31, 2016
Completion
Apr 30, 2016
Last update posted
Jun 25, 2018

2010 – 2016

United States locations

U.S. sites
1
U.S. states
1
U.S. cities
1
Facility City State ZIP Site status
Univeristy of Iowa/ VA Iowa City VA Medical Center Iowa City Iowa 52246

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01381354, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 25, 2018 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01381354 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →